Mozobil Tip Card

By IMF Admin on January 30, 2011 2:04 PM | No Comments

Mozobil Tip Card

In Search Of The Myeloma Stem Cell: A Special Report

By IMF Admin on January 30, 2011 9:00 AM | 1 Comment

In Search Of The Myeloma Stem Cell: A Special Report

IMF Around the Globe: Israeli Association of Myeloma Patients

By IMF Admin on January 29, 2011 6:04 AM | No Comments

IMF Around the Globe: Israeli Association of Myeloma Patients

Myeloma 101

By IMF Admin on January 28, 2011 8:05 AM | No Comments

Myeloma 101

Chapter Three: Symptom Management at Home

By IMF Admin on January 28, 2011 8:05 AM | No Comments

Chapter Three: Symptom Management at Home

Member Events

By IMF Admin on January 27, 2011 12:58 AM | No Comments

Member Events

Case Studies in the Management of Venous Thromboembolic Events and Peripheral Neuropathy in Multiple Myeloma

By IMF Admin on January 27, 2011 12:53 AM | No Comments

Case Studies in the Management of Venous Thromboembolic Events and Peripheral Neuropathy in Multiple Myeloma

Myeloma Manager™
Personal Care Assistant™ Version 4.0.2

By IMF Admin on January 26, 2011 1:22 PM | No Comments

Myeloma Manager™
Personal Care Assistant™ Version 4.0.2

THE INTERNATIONAL MYELOMA FOUNDATION SAYS NEW THALIDOMIDE DATA CONFIRMS SURVIVAL BENEFITS FOR OLDER PATIENTS

By IMF Admin on January 25, 2011 2:30 PM | No Comments

THE INTERNATIONAL MYELOMA FOUNDATION SAYS NEW THALIDOMIDE DATA CONFIRMS SURVIVAL BENEFITS FOR OLDER PATIENTS

Unorthodox Cancer Therapy

By IMF Admin on January 25, 2011 12:34 PM | No Comments

Unorthodox Cancer Therapy

Dr. Knop - The Efficacy and Safety of RAD (Lenalidomide, Adriamycin and Dexamethasone) In Newly Diagnosed Multiple Myeloma ? First Results of a Phase II Trial by the German DSMM Group

By IMF Admin on January 24, 2011 1:24 PM | No Comments

Dr. Knop - The Efficacy and Safety of RAD (Lenalidomide, Adriamycin and Dexamethasone) In Newly Diagnosed Multiple Myeloma ? First Results of a Phase II Trial by the German DSMM Group

Special Gala Report - IMF 3rd Annual Comedy Celebration

By IMF Admin on January 20, 2011 2:07 PM | No Comments

Special Gala Report - IMF 3rd Annual Comedy Celebration

ASH 2009: Irene Ghobrial
Phase II Trial of Weekly Bortezomib in Combination with CCI-779 (temsirolimus) in Relapsed or Relapsed/Refractory Multiple Myeloma

By IMF Admin on January 18, 2011 2:01 PM | No Comments

ASH 2009: Irene Ghobrial
Phase II Trial of Weekly Bortezomib in Combination with CCI-779 (temsirolimus) in Relapsed or Relapsed/Refractory Multiple Myeloma

Online Support Group -- a.k.a., the ListServ

By IMF Admin on January 18, 2011 5:46 AM | No Comments

Online Support Group -- a.k.a., the ListServ

ASCO 2010: Multiple myeloma is characterized by widespread epigenomic alterations with prognostic implications.

By IMF Admin on January 17, 2011 2:02 PM | No Comments

ASCO 2010: Multiple myeloma is characterized by widespread epigenomic alterations with prognostic implications.

Myeloma Minute
June 15, 2010

By IMF Admin on January 17, 2011 1:59 PM | No Comments

Myeloma Minute
June 15, 2010

Understanding Thalidomide Therapy

By IMF Admin on January 16, 2011 3:56 PM | No Comments

Understanding Thalidomide Therapy

Myeloma Today Spring 2009 in PDF

By IMF Admin on January 16, 2011 3:56 PM | No Comments

Myeloma Today Spring 2009 in PDF

Matching Gifts / Corporate Responsibility

By IMF Admin on January 16, 2011 1:57 PM | No Comments

Matching Gifts / Corporate Responsibility

Myeloma Top Ten

By IMF Admin on January 16, 2011 8:03 AM | No Comments

Myeloma Top Ten

Prediction of response and progression in multiple myeloma (MM) with serum-free light chains (sFLC): Corroboration of the International Myeloma Working Group (IMWG) criteria.

By IMF Admin on January 15, 2011 1:52 PM | No Comments

Prediction of response and progression in multiple myeloma (MM) with serum-free light chains (sFLC): Corroboration of the International Myeloma Working Group (IMWG) criteria.

Myeloma Minute
July 19, 2010

By IMF Admin on January 14, 2011 1:46 PM | No Comments

Myeloma Minute
July 19, 2010

Ein

By IMF Admin on January 14, 2011 9:37 AM | No Comments

Ein

First Teleconference of 2011
Best of ASH ? What Patients Need to Know

By IMF Admin on January 13, 2011 3:57 PM | 1 Comment

First Teleconference of 2011
Best of ASH ? What Patients Need to Know

Audio Recording of Consensus on Care: Management of Side Effects of Novel Therapies Teleconference

By IMF Admin on January 11, 2011 1:32 PM | No Comments

Audio Recording of Consensus on Care: Management of Side Effects of Novel Therapies Teleconference

Contact The Development Department

By IMF Admin on January 10, 2011 1:23 PM | No Comments

Contact The Development Department

Organize Your Member Fundraiser

By IMF Admin on January 9, 2011 1:28 PM | No Comments

Organize Your Member Fundraiser

Welcome to the International Myeloma Foundation's Blogs

By IMF Admin on January 8, 2011 3:40 PM | 5 Comments

Welcome to the International Myeloma Foundation's Blogs

International Myeloma Foundation Patient Handbook-- Korean Language Edition

By IMF Admin on January 7, 2011 1:24 PM | No Comments

International Myeloma Foundation Patient Handbook-- Korean Language Edition

Advocacy Toolkit

By IMF Admin on January 7, 2011 1:08 PM | No Comments

Advocacy Toolkit

Click to Talk

By IMF Admin on January 7, 2011 3:21 AM | 25 Comments

Click to Talk

The International Myeloma Foundation and the Mario A. Schirinzi Association of Central Italy Join Forces in the Fight Against Multiple Myeloma

By IMF Admin on January 6, 2011 1:25 PM | No Comments

The International Myeloma Foundation and the Mario A. Schirinzi Association of Central Italy Join Forces in the Fight Against Multiple Myeloma

January 2011 Archives : Discussions About IMF Web Site Content

Mozobil Tip Card

In Search Of The Myeloma Stem Cell: A Special Report

IMF Around the Globe: Israeli Association of Myeloma Patients

Myeloma 101

Chapter Three: Symptom Management at Home

Member Events

Case Studies in the Management of Venous Thromboembolic Events and Peripheral Neuropathy in Multiple Myeloma

Myeloma Manager™
Personal Care Assistant™ Version 4.0.2

THE INTERNATIONAL MYELOMA FOUNDATION SAYS NEW THALIDOMIDE DATA CONFIRMS SURVIVAL BENEFITS FOR OLDER PATIENTS

Unorthodox Cancer Therapy

Dr. Knop - The Efficacy and Safety of RAD (Lenalidomide, Adriamycin and Dexamethasone) In Newly Diagnosed Multiple Myeloma ? First Results of a Phase II Trial by the German DSMM Group

Special Gala Report - IMF 3rd Annual Comedy Celebration

ASH 2009: Irene Ghobrial
Phase II Trial of Weekly Bortezomib in Combination with CCI-779 (temsirolimus) in Relapsed or Relapsed/Refractory Multiple Myeloma

Online Support Group -- a.k.a., the ListServ

ASCO 2010: Multiple myeloma is characterized by widespread epigenomic alterations with prognostic implications.

Myeloma Minute
June 15, 2010

Understanding Thalidomide Therapy

Myeloma Today Spring 2009 in PDF

Matching Gifts / Corporate Responsibility

Myeloma Top Ten

Prediction of response and progression in multiple myeloma (MM) with serum-free light chains (sFLC): Corroboration of the International Myeloma Working Group (IMWG) criteria.

Myeloma Minute
July 19, 2010

Ein

First Teleconference of 2011
Best of ASH ? What Patients Need to Know

Audio Recording of Consensus on Care: Management of Side Effects of Novel Therapies Teleconference

Contact The Development Department

Organize Your Member Fundraiser

Welcome to the International Myeloma Foundation's Blogs

International Myeloma Foundation Patient Handbook-- Korean Language Edition

Advocacy Toolkit

Click to Talk

The International Myeloma Foundation and the Mario A. Schirinzi Association of Central Italy Join Forces in the Fight Against Multiple Myeloma

Report from ASCO 2006

ESAs not the culprit: More studies required